{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:20:25Z","timestamp":1788236425985,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":549,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.exphem.2024.104694","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T11:49:16Z","timestamp":1733485756000},"page":"104694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["RNA methylation: where to from here for hematologic malignancies?"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3134-0596","authenticated-orcid":false,"given":"Andrew Adel","family":"Guirguis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2024.104694_bib0001","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0092-8674(75)90159-2","article-title":"The methylated constituents of L cell messenger RNA: evidence for an unusual cluster at the 5\u2032 terminus","volume":"4","author":"Perry","year":"1975","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0002","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","article-title":"Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells","volume":"71","author":"Desrosiers","year":"1974","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2024.104694_bib0003","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","article-title":"Dynamic RNA modifications in gene expression regulation","volume":"169","author":"Roundtree","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0004","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3\u2013METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.exphem.2024.104694_bib0005","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41586-019-1016-7","article-title":"Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally","volume":"567","author":"Huang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104694_bib0006","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility","volume":"49","author":"Zheng","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0007","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.exphem.2024.104694_bib0008","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N6-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"m6A-Dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104694_bib0010","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear m6A reader YTHDC1 regulates mRNA splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0011","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.4416","article-title":"The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2024.104694_bib0012","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104694_bib0013","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","article-title":"The m6A methyltransferase METTL3 promotes translation in human cancer cells","volume":"62","author":"Lin","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0014","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.exphem.2024.104694_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.stem.2020.04.009","article-title":"RNA demethylase ALKBH5 selectively promotes tumorigenesis and cancer stem cell self-renewal in acute myeloid leukemia","volume":"27","author":"Shen","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0016","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nchembio.482","article-title":"Grand challenge commentary: RNA epigenetics?","volume":"6","author":"He","year":"2010","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.exphem.2024.104694_bib0017","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/d41573-019-00179-5","article-title":"Chemical inhibitors make their RNA epigenetic mark","volume":"18","author":"Cully","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.exphem.2024.104694_bib0018","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104694_bib0019","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/jacsau.4c00040","article-title":"Proteolysis targeting chimera degraders of the METTL3-14 m6A-RNA methyltransferase","volume":"4","author":"Errani","year":"2024","journal-title":"JACS Au"},{"key":"10.1016\/j.exphem.2024.104694_bib0020","article-title":"Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy","author":"Liu","year":"2024","journal-title":"Acta Pharmacol Sin B"},{"key":"10.1016\/j.exphem.2024.104694_bib0021","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1016\/j.celrep.2019.02.100","article-title":"Discovery of small molecules that activate RNA methylation through cooperative binding to the METTL3-14-WTAP complex active site","volume":"26","author":"Selberg","year":"2019","journal-title":"Cell Reports"},{"key":"10.1016\/j.exphem.2024.104694_bib0022","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1158\/2159-8290.CD-23-0007","article-title":"Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity","volume":"13","author":"Guirguis","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.exphem.2024.104694_bib0023","article-title":"m6A methylation in cardiovascular diseases: from mechanisms to therapeutic potential","volume":"13","author":"Li","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.exphem.2024.104694_bib0024","doi-asserted-by":"crossref","first-page":"15957","DOI":"10.1021\/acsomega.1c01626","article-title":"HIV replication is increased by RNA methylation METTL3\/METTL14\/WTAP complex activators","volume":"6","author":"Selberg","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.exphem.2024.104694_bib0025","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41467-021-21904-y","article-title":"N6-methyladenosine RNA modification suppresses antiviral innate sensing pathways via reshaping double-stranded RNA","volume":"12","author":"Qiu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2024.104694_bib0026","doi-asserted-by":"crossref","unstructured":"Jiang L, Roberts R, Wong M, et al. Accumulation of m6A exhibits stronger correlation with MAPT than \u03b2-amyloid pathology in an APPNL-G-F\/MAPTP301S mouse model of Alzheimer's disease. 2023;bioRxiv 2023.03.28.534515. doi:10.1101\/2023.03.28.534515","DOI":"10.21203\/rs.3.rs-2745852\/v1"},{"key":"10.1016\/j.exphem.2024.104694_bib0027","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/cr.2014.3","article-title":"Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase","volume":"24","author":"Ping","year":"2014","journal-title":"Cell Res"},{"key":"10.1016\/j.exphem.2024.104694_bib0028","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104694_bib0029","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.cell.2017.01.013","article-title":"Gene essentiality profiling reveals gene networks and synthetic lethal interactions with oncogenic Ras","volume":"168","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0031","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.stem.2020.04.001","article-title":"Leukemogenic chromatin alterations promote AML leukemia stem cells via a KDM4C\u2013ALKBH5\u2013AXL signaling axis","volume":"27","author":"Wang","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0032","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.stem.2020.06.009","article-title":"Rubbing out leukemia stem cells by erasing the eraser","volume":"27","author":"Cheng","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0033","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0034","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature21022","article-title":"Reversible methylation of m6Am in the 5\u2032 cap controls mRNA stability","volume":"541","author":"Mauer J Luo","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104694_bib0036","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG exhibits anti-tumor activity by targeting FTO\/m6A\/MYC\/CEBPA signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0037","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","article-title":"Targeting the RNA m6A reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia","volume":"25","author":"Paris","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0038","article-title":"The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function","volume":"218","author":"Mapperley","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2024.104694_bib0039","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/0008-5472.CAN-21-4249","article-title":"The RNA m6A reader YTHDF1 is required for acute myeloid leukemia progression","volume":"83","author":"Hong","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2024.104694_bib0040","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ccell.2021.04.017","article-title":"N6-methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation","volume":"39","author":"Cheng","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0041","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.immuni.2020.05.003","article-title":"m6A Modification prevents formation of endogenous double-stranded RNAs and deleterious innate immune responses during hematopoietic development","volume":"52","author":"Gao","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2024.104694_bib0042","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature23883","article-title":"m6A modulates haematopoietic stem and progenitor cell specification","volume":"549","author":"Zhang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104694_bib0043","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41422-018-0062-2","article-title":"Mettl3\u2013Mettl14 methyltransferase complex regulates the quiescence of adult hematopoietic stem cells","volume":"28","author":"Yao","year":"2018","journal-title":"Cell Res"},{"key":"10.1016\/j.exphem.2024.104694_bib0044","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.celrep.2019.07.032","article-title":"m6A RNA methylation maintains hematopoietic stem cell identity and symmetric commitment","volume":"28","author":"Cheng","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2024.104694_bib0045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41420-024-02203-z","article-title":"YTHDC1-mediated microRNA maturation is essential for hematopoietic stem cells maintenance","volume":"10","author":"Zuo","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.exphem.2024.104694_bib0046","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-017-0410-6","article-title":"Genetic alterations of m6A regulators predict poorer survival in acute myeloid leukemia","volume":"10","author":"Kwok","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.exphem.2024.104694_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2020.09.193","article-title":"The old and the new: DNA and RNA methylation in normal and malignant hematopoiesis","volume":"90","author":"Guirguis","year":"2020","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2024.104694_bib0048","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41556-019-0318-1","article-title":"Stage-specific requirement for Mettl3-dependent m6A mRNA methylation during haematopoietic stem cell differentiation","volume":"21","author":"Lee","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2024.104694_bib0049","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.TARG-23-C077","article-title":"Abstract C077: STC-15, a small molecule inhibitor of the RNA methyltransferase METTL3, activates anti-tumor immunity and reshapes the tumor microenvironment","volume":"22","author":"Ofir-Rosenfeld","year":"2023","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.exphem.2024.104694_bib0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104694_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.659595","article-title":"Allogeneic stem cell transplantation for acute myeloid leukemia: who, when, and how?","volume":"12","author":"Loke","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2024.104694_bib0052","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/bjh.18326","article-title":"Enhanced stimulation of antigen-specific immune responses against nucleophosmin 1 mutated acute myeloid leukaemia by an anti-programmed death 1 antibody","volume":"198","author":"Greiner","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2024.104694_bib0053","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104694_bib0054","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41375-023-01965-2","article-title":"Pharmacological inhibition of METTL3 impacts specific haematopoietic lineages","volume":"37","author":"Sturgess","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2024.104694_bib0055","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1080\/15476286.2016.1201628","article-title":"m6A: Signaling for mRNA splicing","volume":"13","author":"Adhikari","year":"2016","journal-title":"RNA Biol"},{"key":"10.1016\/j.exphem.2024.104694_bib0056","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/j.celrep.2018.05.077","article-title":"Transient N-6-methyladenosine transcriptome sequencing reveals a regulatory role of m6A in splicing efficiency","volume":"23","author":"Louloupi","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2024.104694_bib0057","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1126\/science.abj9090","article-title":"Exon architecture controls mRNA m6A suppression and gene expression","volume":"379","author":"He","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.exphem.2024.104694_bib0058","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.molcel.2022.12.026","article-title":"Exclusion of m6A from splice-site proximal regions by the exon junction complex dictates m6A topologies and mRNA stability","volume":"83","author":"Uzonyi","year":"2023","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-39897-1","article-title":"Exon-intron boundary inhibits m6A deposition, enabling m6A distribution hallmark, longer mRNA half-life and flexible protein coding","volume":"14","author":"Luo","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2024.104694_bib82","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1038\/s41467-022-35643-1","article-title":"Exon junction complex shapes the m6A epitranscriptome","volume":"13","author":"Yang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2024.104694_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.gde.2024.102211","article-title":"Interplay between N6-adenosine RNA methylation and mRNA splicing","volume":"87","author":"Mehravar","year":"2024","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.exphem.2024.104694_bib0060","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.molcel.2023.02.024","article-title":"m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis","volume":"83","author":"Cie\u015bla","year":"2023","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0061","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104694_bib0062","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/s41375-024-02228-4","article-title":"Impaired binding affinity of YTHDC1 with METTL3\/METTL14 results in R-loop accumulation in myelodysplastic neoplasms with DDX41 mutation","volume":"38","author":"Hwang","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2024.104694_bib0063","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/gcc.22784","article-title":"Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies","volume":"58","author":"Taylor","year":"2019","journal-title":"Genes Chromosome Cancer"},{"key":"10.1016\/j.exphem.2024.104694_bib0064","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104694_bib0065","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1470-2045(21)00005-X","article-title":"Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study","volume":"22","author":"Kuruvilla","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.exphem.2024.104694_bib0066","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood-2023-189993","article-title":"EP102: pharmacological inhibition of METTL3 elicits tumor growth inhibition in vivo and demonstrates synergy with venetoclax in various AML models","volume":"142","author":"Fraser","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104694_bib0067","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1158\/1538-7445.AM2023-6282","article-title":"Abstract 6282: EP102: pharmacological inhibition of METTL3 arrests tumor progression and prolongs survival in CDX and PDX models of AML","volume":"83","author":"Fraser","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2024.104694_bib0068","doi-asserted-by":"crossref","first-page":"17963","DOI":"10.1021\/ja3064149","article-title":"Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor","volume":"134","author":"Chen","year":"2012","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.exphem.2024.104694_bib0069","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/nar\/gku1276","article-title":"Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5","volume":"43","author":"Huang","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2024.104694_bib0070","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1016\/j.molcel.2021.06.031","article-title":"METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation","volume":"81","author":"Orellana","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2024.104694_bib0071","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/s41467-022-29125-7","article-title":"N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR\/ULK1\/autophagy axis","volume":"13","author":"Han","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2024.104694_bib0072","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1002\/ctm2.661","article-title":"METTL1 promotes hepatocarcinogenesis via m7G tRNA modification-dependent translation control","volume":"11","author":"Chen","year":"2021","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.exphem.2024.104694_bib0073","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026518","article-title":"TET2 in normal and malignant hematopoiesis","volume":"7","author":"Bowman","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.exphem.2024.104694_bib0074","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1182\/blood-2011-02-339747","article-title":"TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics","volume":"118","author":"Chou","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104694_bib0075","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104694_bib0076","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMc091348","article-title":"Mutation in TET2 in myeloid cancers","volume":"361","author":"Tefferi","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104694_bib0077","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1101\/gad.276568.115","article-title":"Role of TET enzymes in DNA methylation, development, and cancer","volume":"30","author":"Rasmussen","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2024.104694_bib0078","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41586-024-07969-x","article-title":"RNA m5C oxidation by TET2 regulates chromatin state and leukaemogenesis","volume":"634","author":"Zou","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104694_bib0079","doi-asserted-by":"crossref","first-page":"e1150","DOI":"10.1002\/iid3.1150","article-title":"m5C regulator-mediated methylation modification patterns and tumor microenvironment infiltration characteristics in acute myeloid leukemia","volume":"12","author":"Wen","year":"2024","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.exphem.2024.104694_bib0080","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41467-018-03513-4","article-title":"RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia","volume":"9","author":"Cheng","year":"2018","journal-title":"Nat Commun"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24005587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24005587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:01:39Z","timestamp":1788235299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X24005587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":82,"alternative-id":["S0301472X24005587"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104694","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA methylation: where to from here for hematologic malignancies?","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Inc. on behalf of International Society for Experimental Hematology.","name":"copyright","label":"Copyright"}],"article-number":"104694"}}